Rare disease caregivers face chronic stress and burnout. Find evidence-based coping strategies for resilience, emotional health, and family stability.
Psychological Coping Strategies for Rare Disease Caregivers
Rare disease caregivers face chronic stress and burnout. Find evidence-based coping strategies for resilience, emotional health, and family stability.
Whole Genome Sequencing: A Guide for Families
A clear, patient-friendly guide to whole genome sequencing, including how it works, what it reveals, and its role in diagnosis and research.
Tay-Sachs Disease: A Clear Guide
A clear, evidence-based guide to Tay-Sachs disease, covering causes, symptoms, inheritance patterns, genetic testing and diagnosis.
Understanding the Rare Disease Diagnostic Journey
Rare disease diagnosis often takes years. Learn why delays occur, the barriers patients face, and how genomic testing is helping improve diagnosis.
Rare Disease as a Systems Challenge: Policy, Data, and Care
Explore rare disease as a systems challenge shaped by governance, data, and care design. See why long horizon, integrated approaches improve outcomes.
How to Interpret “Breakthrough” Treatment Claims in Rare Diseases
Learn how to critically assess “breakthrough” treatment claims in rare disease research. Understand evidence stages, avoid hype cycles, and set realistic expectations based on science.
Reshaping Rare Disease Care: The Role of Genetic Testing and Counselling
Learn how genetic testing and counselling work in rare diseases, and how this integrated approach supports earlier diagnosis and informed care.
Supporting Your Child's Mental Health Through Chronic Illness
Support your child’s mental health through chronic illness with practical strategies to build resilience, encourage communication, and strengthen support systems.
Palliative And Supportive Care For Rare Disease Families
Explore how palliative and supportive care help children with rare diseases manage symptoms and improve quality of life for families.
Endpoints in Rare Disease Clinical Trials
Explore how endpoints are defined in rare disease clinical trials, the challenges of small populations, and the growing role of patient-reported outcomes in regulatory decisions.